This world-first “plasma pathway” policy will allow most people, including gay and bisexual men, to donate plasma immediately ...

A team led by the University of Sydney has identified red blood cell rupture at dying endothelial sites as a primary driver ...

When Cells at Work! hit theaters in Japan, nobody expected it to become one of the year’s biggest cultural surprises.

Sickle cell disease is a chronic blood disorder that requires careful management, not only through medications and medical care but also through proper ...

Researchers have identified a previously unknown biological process that causes tissue and organ damage in conditions where ...

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

LifeServe Blood Center kicks off Blood Donor Day next week. The event encourages first-time and regular donors to roll up their sleeves to save lives. You can donate blood ...

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds ...